| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniosynostoses | 17 | 2023 | 77 | 5.400 |
Why?
|
| Osteogenesis, Distraction | 11 | 2022 | 24 | 3.800 |
Why?
|
| Mandible | 13 | 2024 | 121 | 3.230 |
Why?
|
| Osteogenesis | 23 | 2020 | 258 | 3.060 |
Why?
|
| Pierre Robin Syndrome | 6 | 2022 | 13 | 3.000 |
Why?
|
| Skull | 13 | 2020 | 255 | 2.840 |
Why?
|
| Cranial Sutures | 9 | 2023 | 47 | 2.470 |
Why?
|
| Growth Differentiation Factor 2 | 18 | 2020 | 154 | 2.390 |
Why?
|
| Airway Obstruction | 6 | 2022 | 109 | 2.210 |
Why?
|
| Cell Differentiation | 22 | 2020 | 1532 | 1.570 |
Why?
|
| Osteoclasts | 5 | 2020 | 36 | 1.400 |
Why?
|
| Bone Transplantation | 5 | 2024 | 67 | 1.290 |
Why?
|
| Temporal Muscle | 2 | 2021 | 12 | 1.250 |
Why?
|
| Tissue Scaffolds | 6 | 2019 | 116 | 1.190 |
Why?
|
| Growth Differentiation Factors | 8 | 2019 | 57 | 1.160 |
Why?
|
| Proteome | 2 | 2018 | 135 | 1.050 |
Why?
|
| Surgical Flaps | 6 | 2015 | 250 | 1.040 |
Why?
|
| Osteoprotegerin | 3 | 2019 | 10 | 1.040 |
Why?
|
| Cleft Palate | 4 | 2022 | 26 | 1.010 |
Why?
|
| Infant | 19 | 2023 | 3185 | 0.990 |
Why?
|
| Printing, Three-Dimensional | 2 | 2023 | 45 | 0.980 |
Why?
|
| Osteotomy | 2 | 2023 | 33 | 0.930 |
Why?
|
| Orthognathic Surgical Procedures | 2 | 2021 | 19 | 0.930 |
Why?
|
| Bone Morphogenetic Proteins | 5 | 2012 | 127 | 0.890 |
Why?
|
| Wounds, Gunshot | 1 | 2024 | 99 | 0.830 |
Why?
|
| Wounds and Injuries | 3 | 2020 | 260 | 0.820 |
Why?
|
| Mastication | 1 | 2023 | 78 | 0.820 |
Why?
|
| Osteoblasts | 6 | 2020 | 97 | 0.770 |
Why?
|
| Humans | 85 | 2024 | 89768 | 0.760 |
Why?
|
| Orthognathic Surgery | 1 | 2021 | 9 | 0.750 |
Why?
|
| Micrognathism | 3 | 2017 | 11 | 0.750 |
Why?
|
| X-Ray Microtomography | 3 | 2019 | 91 | 0.730 |
Why?
|
| Nanocomposites | 1 | 2019 | 14 | 0.670 |
Why?
|
| Facial Bones | 4 | 2022 | 37 | 0.660 |
Why?
|
| Trauma Centers | 1 | 2020 | 146 | 0.660 |
Why?
|
| Adipocytes | 3 | 2019 | 163 | 0.660 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2019 | 86 | 0.650 |
Why?
|
| Signal Transduction | 10 | 2023 | 3402 | 0.640 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2020 | 2674 | 0.640 |
Why?
|
| Craniofacial Abnormalities | 6 | 2020 | 36 | 0.640 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 319 | 0.620 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 305 | 0.620 |
Why?
|
| Proteomics | 2 | 2018 | 232 | 0.610 |
Why?
|
| Betacoronavirus | 2 | 2020 | 262 | 0.600 |
Why?
|
| Wound Healing | 5 | 2006 | 361 | 0.580 |
Why?
|
| Transduction, Genetic | 2 | 2017 | 160 | 0.570 |
Why?
|
| Osseointegration | 1 | 2017 | 11 | 0.570 |
Why?
|
| Fracture Healing | 1 | 2017 | 36 | 0.560 |
Why?
|
| Pandemics | 4 | 2021 | 778 | 0.550 |
Why?
|
| Cicatrix, Hypertrophic | 2 | 2006 | 8 | 0.530 |
Why?
|
| Mice | 21 | 2019 | 11846 | 0.510 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 603 | 0.510 |
Why?
|
| Preoperative Care | 1 | 2018 | 395 | 0.510 |
Why?
|
| Retrospective Studies | 16 | 2022 | 9156 | 0.500 |
Why?
|
| Biocompatible Materials | 7 | 2019 | 198 | 0.500 |
Why?
|
| Rhytidoplasty | 1 | 2015 | 12 | 0.500 |
Why?
|
| Facial Paralysis | 1 | 2015 | 17 | 0.500 |
Why?
|
| Fascia | 1 | 2015 | 31 | 0.500 |
Why?
|
| Animals | 29 | 2023 | 27511 | 0.490 |
Why?
|
| Surgery, Plastic | 4 | 2021 | 42 | 0.490 |
Why?
|
| Cell Line | 12 | 2019 | 2495 | 0.460 |
Why?
|
| Child, Preschool | 11 | 2020 | 3762 | 0.460 |
Why?
|
| Protective Devices | 2 | 2013 | 8 | 0.460 |
Why?
|
| Oral Surgical Procedures | 3 | 2010 | 19 | 0.450 |
Why?
|
| Skin | 4 | 2009 | 589 | 0.440 |
Why?
|
| External Fixators | 1 | 2013 | 19 | 0.430 |
Why?
|
| Male | 37 | 2024 | 42578 | 0.430 |
Why?
|
| Electromagnetic Fields | 1 | 2012 | 26 | 0.400 |
Why?
|
| Tissue Engineering | 4 | 2019 | 191 | 0.400 |
Why?
|
| Stem Cell Transplantation | 2 | 2012 | 189 | 0.400 |
Why?
|
| Face | 1 | 2012 | 118 | 0.390 |
Why?
|
| Ear, External | 2 | 2010 | 26 | 0.390 |
Why?
|
| Adipogenesis | 3 | 2018 | 39 | 0.380 |
Why?
|
| RANK Ligand | 1 | 2011 | 10 | 0.380 |
Why?
|
| Treatment Outcome | 12 | 2022 | 8240 | 0.370 |
Why?
|
| Genetic Vectors | 5 | 2018 | 446 | 0.350 |
Why?
|
| Surgery Department, Hospital | 2 | 2020 | 44 | 0.340 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 283 | 0.330 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2009 | 5 | 0.330 |
Why?
|
| HEK293 Cells | 7 | 2020 | 646 | 0.330 |
Why?
|
| Mandibular Fractures | 1 | 2009 | 7 | 0.330 |
Why?
|
| Infant, Newborn | 8 | 2020 | 2496 | 0.330 |
Why?
|
| Absorbable Implants | 1 | 2009 | 35 | 0.320 |
Why?
|
| Female | 32 | 2020 | 46491 | 0.320 |
Why?
|
| Arteriovenous Malformations | 2 | 2010 | 45 | 0.310 |
Why?
|
| Homeostasis | 1 | 2011 | 418 | 0.310 |
Why?
|
| Tongue | 3 | 2022 | 57 | 0.310 |
Why?
|
| Precision Medicine | 1 | 2012 | 412 | 0.300 |
Why?
|
| Child | 13 | 2020 | 7231 | 0.300 |
Why?
|
| Calcium-Binding Proteins | 2 | 2020 | 121 | 0.300 |
Why?
|
| Surgical Wound Infection | 4 | 2015 | 201 | 0.300 |
Why?
|
| Adenoviridae | 4 | 2017 | 349 | 0.300 |
Why?
|
| Postoperative Complications | 7 | 2018 | 2299 | 0.300 |
Why?
|
| Maxillofacial Development | 1 | 2007 | 4 | 0.290 |
Why?
|
| Adolescent | 11 | 2020 | 9325 | 0.290 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 1134 | 0.290 |
Why?
|
| Models, Anatomic | 3 | 2023 | 92 | 0.280 |
Why?
|
| Frontal Bone | 3 | 2018 | 16 | 0.280 |
Why?
|
| Genetic Therapy | 2 | 2006 | 372 | 0.270 |
Why?
|
| Recurrence | 4 | 2022 | 1143 | 0.270 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2006 | 45 | 0.260 |
Why?
|
| Ischemia | 2 | 2006 | 252 | 0.260 |
Why?
|
| Bone and Bones | 6 | 2019 | 271 | 0.260 |
Why?
|
| Eyelids | 1 | 2006 | 23 | 0.260 |
Why?
|
| Metalloendopeptidases | 1 | 2006 | 44 | 0.260 |
Why?
|
| Endoscopy | 2 | 2021 | 352 | 0.260 |
Why?
|
| Oculomotor Muscles | 1 | 2006 | 30 | 0.260 |
Why?
|
| Cells, Cultured | 6 | 2019 | 2887 | 0.260 |
Why?
|
| Lipectomy | 1 | 2005 | 9 | 0.260 |
Why?
|
| Hernia, Umbilical | 1 | 2005 | 17 | 0.250 |
Why?
|
| Stem Cells | 4 | 2019 | 376 | 0.250 |
Why?
|
| Abdominal Wall | 1 | 2005 | 30 | 0.250 |
Why?
|
| Adult | 12 | 2024 | 26762 | 0.250 |
Why?
|
| Temporomandibular Joint Disorders | 2 | 2020 | 21 | 0.240 |
Why?
|
| Adipose Tissue | 2 | 2018 | 262 | 0.240 |
Why?
|
| Ulnar Artery | 1 | 2004 | 5 | 0.240 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 2016 | 0.240 |
Why?
|
| Facial Injuries | 1 | 2024 | 20 | 0.240 |
Why?
|
| Registries | 3 | 2018 | 792 | 0.240 |
Why?
|
| Sutures | 2 | 2023 | 57 | 0.230 |
Why?
|
| Biomechanical Phenomena | 2 | 2023 | 477 | 0.230 |
Why?
|
| Case-Control Studies | 2 | 2020 | 1864 | 0.230 |
Why?
|
| Maxilla | 2 | 2018 | 20 | 0.230 |
Why?
|
| Esophageal Fistula | 1 | 2004 | 11 | 0.230 |
Why?
|
| Suction | 1 | 2003 | 37 | 0.230 |
Why?
|
| Disease Models, Animal | 4 | 2006 | 2391 | 0.220 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 326 | 0.220 |
Why?
|
| beta Catenin | 4 | 2022 | 267 | 0.220 |
Why?
|
| Free Tissue Flaps | 2 | 2015 | 49 | 0.220 |
Why?
|
| Up-Regulation | 4 | 2018 | 726 | 0.220 |
Why?
|
| Internship and Residency | 3 | 2021 | 1062 | 0.220 |
Why?
|
| Primary Cell Culture | 2 | 2020 | 77 | 0.210 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 1799 | 0.210 |
Why?
|
| Spinal Fusion | 1 | 2004 | 86 | 0.210 |
Why?
|
| Gelatin | 3 | 2017 | 26 | 0.210 |
Why?
|
| Pyrvinium Compounds | 1 | 2022 | 5 | 0.210 |
Why?
|
| Calcification, Physiologic | 3 | 2019 | 33 | 0.210 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 144 | 0.200 |
Why?
|
| Muscle, Skeletal | 2 | 2009 | 471 | 0.200 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2016 | 218 | 0.190 |
Why?
|
| Practice Patterns, Dentists' | 1 | 2021 | 3 | 0.190 |
Why?
|
| Trismus | 1 | 2021 | 6 | 0.190 |
Why?
|
| Cephalometry | 3 | 2017 | 50 | 0.190 |
Why?
|
| Ulna | 1 | 2021 | 15 | 0.190 |
Why?
|
| Neovascularization, Physiologic | 2 | 2017 | 143 | 0.190 |
Why?
|
| Prescriptions | 1 | 2021 | 23 | 0.190 |
Why?
|
| Immunoenzyme Techniques | 2 | 2012 | 303 | 0.190 |
Why?
|
| Clinical Protocols | 2 | 2020 | 158 | 0.190 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1983 | 0.190 |
Why?
|
| Gene Transfer Techniques | 2 | 2015 | 153 | 0.180 |
Why?
|
| Abnormalities, Multiple | 2 | 2020 | 234 | 0.180 |
Why?
|
| Universities | 1 | 2021 | 145 | 0.180 |
Why?
|
| Polysomnography | 2 | 2017 | 151 | 0.170 |
Why?
|
| Chondrogenesis | 2 | 2018 | 28 | 0.170 |
Why?
|
| Language Development Disorders | 1 | 2020 | 24 | 0.170 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 46 | 0.170 |
Why?
|
| Emergencies | 1 | 2020 | 122 | 0.170 |
Why?
|
| Models, Animal | 2 | 2015 | 277 | 0.170 |
Why?
|
| Cleft Lip | 1 | 2019 | 15 | 0.170 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 4 | 2013 | 23 | 0.170 |
Why?
|
| Anemia | 1 | 2020 | 132 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 885 | 0.170 |
Why?
|
| Reoperation | 3 | 2017 | 604 | 0.160 |
Why?
|
| Bone Resorption | 1 | 2019 | 42 | 0.160 |
Why?
|
| Databases, Factual | 1 | 2023 | 860 | 0.160 |
Why?
|
| Wnt Proteins | 2 | 2011 | 130 | 0.160 |
Why?
|
| Operating Rooms | 1 | 2020 | 125 | 0.160 |
Why?
|
| Bioprinting | 1 | 2019 | 13 | 0.160 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 128 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 124 | 0.160 |
Why?
|
| Obesity | 1 | 2005 | 972 | 0.160 |
Why?
|
| RNA, Messenger | 2 | 2018 | 2025 | 0.160 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 256 | 0.160 |
Why?
|
| Fibroblasts | 4 | 2020 | 759 | 0.160 |
Why?
|
| Health Policy | 1 | 2020 | 188 | 0.160 |
Why?
|
| Umbilical Cord | 1 | 2018 | 40 | 0.160 |
Why?
|
| Intellectual Disability | 1 | 2020 | 189 | 0.160 |
Why?
|
| Nanoparticles | 2 | 2019 | 164 | 0.160 |
Why?
|
| Hydrogels | 1 | 2019 | 87 | 0.150 |
Why?
|
| Strontium | 1 | 2018 | 6 | 0.150 |
Why?
|
| Collagen Type VI | 1 | 2018 | 5 | 0.150 |
Why?
|
| Cerebellum | 2 | 2020 | 249 | 0.150 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 996 | 0.150 |
Why?
|
| Chicago | 2 | 2020 | 1431 | 0.150 |
Why?
|
| Equipment Design | 2 | 2013 | 420 | 0.150 |
Why?
|
| Receptors, Notch | 1 | 2018 | 126 | 0.150 |
Why?
|
| Peptides, Cyclic | 1 | 2018 | 44 | 0.150 |
Why?
|
| Citric Acid | 1 | 2018 | 44 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 289 | 0.150 |
Why?
|
| Polyethylene Glycols | 2 | 2017 | 360 | 0.150 |
Why?
|
| Proteoglycans | 1 | 2018 | 123 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 104 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 127 | 0.140 |
Why?
|
| Biotechnology | 1 | 2017 | 28 | 0.140 |
Why?
|
| Mice, Knockout | 3 | 2015 | 2015 | 0.140 |
Why?
|
| Genomics | 1 | 2023 | 776 | 0.140 |
Why?
|
| Propensity Score | 1 | 2018 | 149 | 0.140 |
Why?
|
| Phosphates | 1 | 2018 | 161 | 0.140 |
Why?
|
| Alkaline Phosphatase | 3 | 2012 | 132 | 0.140 |
Why?
|
| Bone Regeneration | 4 | 2019 | 62 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2020 | 443 | 0.140 |
Why?
|
| Bone Matrix | 2 | 2014 | 19 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 315 | 0.140 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 2018 | 47 | 0.140 |
Why?
|
| Founder Effect | 1 | 2017 | 104 | 0.140 |
Why?
|
| Durapatite | 1 | 2016 | 31 | 0.140 |
Why?
|
| Genetic Engineering | 1 | 2017 | 115 | 0.140 |
Why?
|
| Rabbits | 3 | 2006 | 640 | 0.140 |
Why?
|
| Follow-Up Studies | 6 | 2013 | 3663 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 451 | 0.140 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 94 | 0.130 |
Why?
|
| Blepharoplasty | 2 | 2006 | 8 | 0.130 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 557 | 0.130 |
Why?
|
| Patient Selection | 1 | 2020 | 678 | 0.130 |
Why?
|
| Ear | 2 | 2006 | 17 | 0.130 |
Why?
|
| Occipital Bone | 1 | 2016 | 18 | 0.130 |
Why?
|
| Prostheses and Implants | 2 | 2009 | 124 | 0.130 |
Why?
|
| Mice, Nude | 5 | 2018 | 816 | 0.130 |
Why?
|
| Aged | 7 | 2020 | 19209 | 0.130 |
Why?
|
| Encephalocele | 1 | 2016 | 26 | 0.130 |
Why?
|
| Cell Proliferation | 6 | 2019 | 1669 | 0.130 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 242 | 0.130 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 194 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 607 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2017 | 235 | 0.130 |
Why?
|
| Smiling | 1 | 2015 | 2 | 0.130 |
Why?
|
| Patient Care Planning | 1 | 2016 | 83 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 401 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2017 | 168 | 0.120 |
Why?
|
| Facial Expression | 1 | 2015 | 51 | 0.120 |
Why?
|
| Osteocalcin | 2 | 2012 | 26 | 0.120 |
Why?
|
| Random Allocation | 1 | 2015 | 327 | 0.120 |
Why?
|
| Young Adult | 4 | 2020 | 6386 | 0.120 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 98 | 0.120 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2015 | 79 | 0.120 |
Why?
|
| Osteopontin | 2 | 2012 | 47 | 0.120 |
Why?
|
| User-Computer Interface | 1 | 2016 | 187 | 0.120 |
Why?
|
| Collagen | 1 | 2016 | 294 | 0.120 |
Why?
|
| Decision Making | 1 | 2020 | 669 | 0.120 |
Why?
|
| Parietal Bone | 1 | 2014 | 20 | 0.120 |
Why?
|
| Skull Fractures | 1 | 2014 | 25 | 0.110 |
Why?
|
| Middle Aged | 8 | 2020 | 26076 | 0.110 |
Why?
|
| Animals, Newborn | 1 | 2015 | 524 | 0.110 |
Why?
|
| Consumer Behavior | 1 | 2013 | 31 | 0.110 |
Why?
|
| Blood Transfusion | 3 | 2020 | 171 | 0.110 |
Why?
|
| Neural Tube Defects | 1 | 2014 | 45 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2019 | 794 | 0.110 |
Why?
|
| Respiratory Aspiration | 1 | 2013 | 5 | 0.110 |
Why?
|
| Craniotomy | 1 | 2014 | 89 | 0.110 |
Why?
|
| Temporal Bone | 1 | 2014 | 68 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 3250 | 0.110 |
Why?
|
| Professional-Family Relations | 1 | 2013 | 54 | 0.110 |
Why?
|
| Maxillofacial Injuries | 1 | 2012 | 4 | 0.110 |
Why?
|
| Gene Expression | 3 | 2019 | 1309 | 0.100 |
Why?
|
| Arm | 1 | 2013 | 99 | 0.100 |
Why?
|
| Equipment Failure | 1 | 2013 | 120 | 0.100 |
Why?
|
| Cerebral Palsy | 1 | 2013 | 97 | 0.100 |
Why?
|
| Head Protective Devices | 1 | 2012 | 20 | 0.100 |
Why?
|
| Cell Adhesion | 3 | 2019 | 426 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 70 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 125 | 0.100 |
Why?
|
| Arteries | 2 | 2013 | 179 | 0.100 |
Why?
|
| Plagiocephaly, Nonsynostotic | 1 | 2011 | 3 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2012 | 133 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6777 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 226 | 0.090 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2010 | 33 | 0.090 |
Why?
|
| Parents | 1 | 2013 | 289 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2013 | 344 | 0.090 |
Why?
|
| Bone Diseases | 1 | 2011 | 57 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2018 | 899 | 0.090 |
Why?
|
| Skull Base | 1 | 2011 | 48 | 0.090 |
Why?
|
| Hydroxyapatites | 1 | 2010 | 7 | 0.090 |
Why?
|
| Molar | 1 | 2010 | 22 | 0.090 |
Why?
|
| Hemostasis, Surgical | 1 | 2010 | 25 | 0.090 |
Why?
|
| Radiographic Image Enhancement | 1 | 2012 | 463 | 0.090 |
Why?
|
| Bandages | 1 | 2010 | 42 | 0.090 |
Why?
|
| Masks | 1 | 2010 | 29 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 309 | 0.080 |
Why?
|
| Scalp | 1 | 2009 | 72 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 34 | 0.080 |
Why?
|
| Polyesters | 1 | 2009 | 42 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2009 | 93 | 0.080 |
Why?
|
| DNA | 1 | 2014 | 1311 | 0.080 |
Why?
|
| Surgical Mesh | 1 | 2009 | 124 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2009 | 276 | 0.080 |
Why?
|
| Ear Neoplasms | 1 | 2008 | 13 | 0.080 |
Why?
|
| Bone Development | 1 | 2008 | 37 | 0.070 |
Why?
|
| Extraoral Traction Appliances | 1 | 2007 | 2 | 0.070 |
Why?
|
| Retrognathia | 1 | 2007 | 3 | 0.070 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2008 | 63 | 0.070 |
Why?
|
| Polymers | 1 | 2009 | 196 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 198 | 0.070 |
Why?
|
| Synostosis | 1 | 2007 | 1 | 0.070 |
Why?
|
| Skin Ulcer | 2 | 2006 | 25 | 0.070 |
Why?
|
| United States | 1 | 2020 | 7080 | 0.070 |
Why?
|
| Osteosarcoma | 1 | 2008 | 161 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 177 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 3062 | 0.070 |
Why?
|
| Cell Division | 1 | 2008 | 692 | 0.070 |
Why?
|
| Time Factors | 2 | 2007 | 5349 | 0.070 |
Why?
|
| Ankylosis | 1 | 2006 | 4 | 0.070 |
Why?
|
| Injections, Intradermal | 1 | 2006 | 19 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 1 | 1 | 2006 | 2 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 1061 | 0.070 |
Why?
|
| Blepharoptosis | 1 | 2006 | 11 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 399 | 0.060 |
Why?
|
| Telomerase | 1 | 2006 | 67 | 0.060 |
Why?
|
| Retroviridae | 1 | 2006 | 79 | 0.060 |
Why?
|
| Temperature | 2 | 2018 | 409 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2018 | 4320 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 280 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2006 | 222 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 840 | 0.060 |
Why?
|
| Granulation Tissue | 1 | 2004 | 15 | 0.060 |
Why?
|
| RNA Interference | 2 | 2017 | 376 | 0.060 |
Why?
|
| Silicones | 2 | 2019 | 20 | 0.060 |
Why?
|
| Syndrome | 2 | 2020 | 450 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2004 | 81 | 0.060 |
Why?
|
| Transfection | 1 | 2006 | 909 | 0.060 |
Why?
|
| Cell Lineage | 3 | 2012 | 293 | 0.060 |
Why?
|
| Esophageal Perforation | 1 | 2004 | 18 | 0.060 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 63 | 0.060 |
Why?
|
| Magnetics | 1 | 2004 | 41 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2003 | 72 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 88 | 0.060 |
Why?
|
| Computer Systems | 1 | 2004 | 79 | 0.060 |
Why?
|
| Iatrogenic Disease | 1 | 2004 | 70 | 0.060 |
Why?
|
| Biomarkers | 2 | 2010 | 1772 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 126 | 0.050 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2017 | 61 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 663 | 0.050 |
Why?
|
| Microsurgery | 1 | 2004 | 91 | 0.050 |
Why?
|
| Periodicity | 1 | 2004 | 119 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 2005 | 239 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2003 | 231 | 0.050 |
Why?
|
| Radiography | 1 | 2004 | 806 | 0.050 |
Why?
|
| Length of Stay | 2 | 2017 | 744 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2005 | 775 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2022 | 99 | 0.050 |
Why?
|
| Comorbidity | 1 | 2005 | 952 | 0.050 |
Why?
|
| Philadelphia | 2 | 2013 | 18 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 919 | 0.050 |
Why?
|
| Mutation | 2 | 2020 | 4164 | 0.050 |
Why?
|
| Algorithms | 1 | 2009 | 1903 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1576 | 0.050 |
Why?
|
| Joint Prosthesis | 1 | 2020 | 26 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2004 | 689 | 0.040 |
Why?
|
| Hospitals, Pediatric | 2 | 2013 | 117 | 0.040 |
Why?
|
| PPAR gamma | 2 | 2012 | 72 | 0.040 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 32 | 0.040 |
Why?
|
| Cerebellar Vermis | 1 | 2020 | 5 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 35 | 0.040 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2020 | 8 | 0.040 |
Why?
|
| Polymicrogyria | 1 | 2020 | 10 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 1244 | 0.040 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2020 | 39 | 0.040 |
Why?
|
| Basilar Artery | 1 | 2020 | 42 | 0.040 |
Why?
|
| Smad Proteins | 2 | 2010 | 43 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 3468 | 0.040 |
Why?
|
| Illinois | 1 | 2021 | 485 | 0.040 |
Why?
|
| Glycosaminoglycans | 1 | 2019 | 47 | 0.040 |
Why?
|
| Chondroitin Sulfates | 1 | 2019 | 43 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 103 | 0.040 |
Why?
|
| Chitosan | 1 | 2019 | 17 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2019 | 88 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2019 | 72 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2019 | 176 | 0.040 |
Why?
|
| Transgenes | 1 | 2019 | 185 | 0.040 |
Why?
|
| Cross Infection | 1 | 2020 | 151 | 0.040 |
Why?
|
| Transposon Resolvases | 1 | 2018 | 7 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2020 | 135 | 0.040 |
Why?
|
| Osteotomy, Le Fort | 1 | 2018 | 6 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2018 | 25 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 77 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 503 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1856 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2018 | 84 | 0.040 |
Why?
|
| Bone Plates | 2 | 2007 | 23 | 0.040 |
Why?
|
| Silicates | 1 | 2017 | 4 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2017 | 7 | 0.040 |
Why?
|
| Graphite | 1 | 2017 | 12 | 0.040 |
Why?
|
| Simian virus 40 | 1 | 2017 | 35 | 0.040 |
Why?
|
| Transformation, Genetic | 1 | 2017 | 41 | 0.040 |
Why?
|
| Critical Care | 1 | 2020 | 384 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 2583 | 0.040 |
Why?
|
| Apoptosis | 1 | 2004 | 1717 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 154 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2018 | 185 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2017 | 140 | 0.030 |
Why?
|
| Antioxidants | 1 | 2018 | 226 | 0.030 |
Why?
|
| North America | 1 | 2017 | 188 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 571 | 0.030 |
Why?
|
| Tectum Mesencephali | 1 | 2016 | 4 | 0.030 |
Why?
|
| Acrylic Resins | 1 | 2016 | 22 | 0.030 |
Why?
|
| Citrates | 1 | 2016 | 28 | 0.030 |
Why?
|
| Mandibular Advancement | 1 | 2016 | 6 | 0.030 |
Why?
|
| Materials Testing | 1 | 2016 | 93 | 0.030 |
Why?
|
| Oropharynx | 1 | 2016 | 15 | 0.030 |
Why?
|
| Internal Fixators | 1 | 2016 | 15 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2003 | 2314 | 0.030 |
Why?
|
| Cartilage | 1 | 2016 | 116 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2016 | 141 | 0.030 |
Why?
|
| Prognosis | 1 | 2004 | 3785 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2016 | 30 | 0.030 |
Why?
|
| Respiratory System | 1 | 2016 | 116 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2017 | 260 | 0.030 |
Why?
|
| Virus Replication | 1 | 2017 | 326 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2017 | 302 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2016 | 111 | 0.030 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2015 | 10 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 690 | 0.030 |
Why?
|
| Meningitis | 1 | 2015 | 21 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 2015 | 55 | 0.030 |
Why?
|
| Wnt3A Protein | 1 | 2014 | 23 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 304 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 995 | 0.030 |
Why?
|
| Rotation | 1 | 2014 | 91 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 983 | 0.030 |
Why?
|
| Veins | 1 | 2013 | 95 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2015 | 332 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 583 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2886 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 95 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 131 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 384 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 179 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 2648 | 0.030 |
Why?
|
| Integrases | 1 | 2012 | 63 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1101 | 0.020 |
Why?
|
| Graft Survival | 1 | 2015 | 907 | 0.020 |
Why?
|
| Petrous Bone | 1 | 2011 | 11 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2010 | 4 | 0.020 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2011 | 25 | 0.020 |
Why?
|
| Temporomandibular Joint | 1 | 2011 | 20 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 21 | 0.020 |
Why?
|
| Cranial Fossa, Middle | 1 | 2011 | 13 | 0.020 |
Why?
|
| Implants, Experimental | 1 | 2010 | 16 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2010 | 67 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 262 | 0.020 |
Why?
|
| Base Sequence | 1 | 2014 | 2329 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2010 | 22 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2010 | 65 | 0.020 |
Why?
|
| Alveolar Bone Loss | 1 | 2010 | 20 | 0.020 |
Why?
|
| Risk Factors | 2 | 2013 | 5538 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2010 | 99 | 0.020 |
Why?
|
| Goldenhar Syndrome | 1 | 2009 | 2 | 0.020 |
Why?
|
| Speech Intelligibility | 1 | 2009 | 10 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1052 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 268 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2010 | 153 | 0.020 |
Why?
|
| Ribs | 1 | 2009 | 46 | 0.020 |
Why?
|
| Fetus | 1 | 2010 | 232 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 869 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 341 | 0.020 |
Why?
|
| Maternal Age | 1 | 2008 | 45 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 103 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 247 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 371 | 0.020 |
Why?
|
| Jaw Fixation Techniques | 1 | 2007 | 4 | 0.020 |
Why?
|
| Titanium | 1 | 2007 | 20 | 0.020 |
Why?
|
| Health Surveys | 1 | 2008 | 240 | 0.020 |
Why?
|
| Esthetics | 1 | 2007 | 45 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1350 | 0.020 |
Why?
|
| Rejuvenation | 1 | 2006 | 21 | 0.020 |
Why?
|
| Malocclusion | 1 | 2006 | 7 | 0.020 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2006 | 14 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 693 | 0.020 |
Why?
|
| Body Image | 1 | 2006 | 79 | 0.020 |
Why?
|
| Arthroplasty | 1 | 2006 | 28 | 0.020 |
Why?
|
| Oxidants | 1 | 2006 | 86 | 0.020 |
Why?
|
| Self Concept | 1 | 2006 | 134 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2006 | 82 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2006 | 344 | 0.020 |
Why?
|
| Sex Factors | 1 | 2008 | 1073 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1008 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2006 | 458 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1158 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 1729 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 1451 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1765 | 0.010 |
Why?
|